These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24003225)

  • 1. Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.
    Fu P; Yang Z; Bach LA
    J Biol Chem; 2013 Oct; 288(41):29890-900. PubMed ID: 24003225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
    Fu P; Liang GJ; Khot SS; Phan R; Bach LA
    J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6.
    Fu P; Thompson JA; Bach LA
    J Biol Chem; 2007 Aug; 282(31):22298-306. PubMed ID: 17519236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor?
    Bach LA
    Growth Horm IGF Res; 2016; 30-31():81-86. PubMed ID: 27681092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell Lines.
    Yang Z; Bach LA
    Front Endocrinol (Lausanne); 2014; 5():231. PubMed ID: 25601855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action.
    Srinivasan N; Edwall D; Linkhart TA; Baylink DJ; Mohan S
    J Endocrinol; 1996 May; 149(2):297-303. PubMed ID: 8708541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
    Zhang C; Lu L; Li Y; Wang X; Zhou J; Liu Y; Fu P; Gallicchio MA; Bach LA; Duan C
    Int J Cancer; 2012 May; 130(9):2003-12. PubMed ID: 21618524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells.
    Zhou Z; Ai H; Li K; Yao X; Zhu W; Liu L; Yu C; Song Z; Bao Y; Huang Y; Wu Y; Zheng L; Sun Y; Wang G; Ma K; Sun L; Li Y
    Sci Rep; 2018 Jan; 8(1):1479. PubMed ID: 29367618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification from transformed mouse fibroblast of a cell growth inhibitor which is an IGF-binding protein.
    Blat C; Villaudy J; Delbé J; Troalen F; Golde A; Harel L
    Growth Factors; 1992; 6(1):65-75. PubMed ID: 1375478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import.
    Iosef C; Gkourasas T; Jia CY; Li SS; Han VK
    Endocrinology; 2008 Mar; 149(3):1214-26. PubMed ID: 18039785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
    Headey SJ; Leeding KS; Norton RS; Bach LA
    J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis.
    Marinaro JA; Neumann GM; Russo VC; Leeding KS; Bach LA
    Eur J Biochem; 2000 Sep; 267(17):5378-86. PubMed ID: 10951195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
    Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
    J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
    Kim SK; Kwon JY; Nam TJ
    Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an insulin-like growth factor binding protein fusion protein on thymidine incorporation in neuroblastoma and rhabdomyosarcoma cell lines.
    Dake BL; Boes M; Bach LA; Bar RS
    Endocrinology; 2004 Jul; 145(7):3369-74. PubMed ID: 15090464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of IGF binding protein synthesis by a bovine mammary epithelial cell line.
    Cohick WS; Turner JD
    J Endocrinol; 1998 May; 157(2):327-36. PubMed ID: 9659296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-6: the "forgotten" binding protein?
    Bach LA
    Horm Metab Res; 1999; 31(2-3):226-34. PubMed ID: 10226806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells.
    Andress DL
    J Biol Chem; 1995 Nov; 270(47):28289-96. PubMed ID: 7499327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.